发明名称 |
IDENTIFICATION, SELECTION AND USE OF HIGH CURATIVE POTENTIAL T CELL EPITOPES |
摘要 |
A method for identifying T-cell epitopes which can be used to elicit T cells targeting cells capable of regenerating cancers is disclosed. The method identifies T-cell epitopes with a high curative potential, high potency and high probability of T cell recognition (HP). The method includes: (i) identifying high curative potential tumor protein target i.e., identifying HP-TP; (ii) identifying peptide sequences within the protein sequence of an HP-TP that have a high probability of eliciting T cell killing; and (iii) qualifying the sequence specificity based on the fold difference between the specific target and non-targets. The identified T-cell epitopes include a core sequence of 9 amino acids homologous to a sequence expressed within a qualified HP-TP. The T-cell epitopes can be used in a method for reprogramming T cells to selectively attack tumor cells capable of perpetuating a tumor and treating patients, for example, cancer patients. |
申请公布号 |
US2016161486(A1) |
申请公布日期 |
2016.06.09 |
申请号 |
US201514958780 |
申请日期 |
2015.12.03 |
申请人 |
Verik Bio, Inc. |
发明人 |
Parenteau Nancy;Laning Joseph;Young Janet |
分类号 |
G01N33/569;C07K14/47;A61K35/17 |
主分类号 |
G01N33/569 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for identifying T-cell epitopes which target cells capable of regenerating cancers comprising: (i) identifying high curative potential tumor protein targets (HP-TP) or auxiliary tumor protein targets (Aux-TP); (ii) identifying peptide sequences within the protein sequence of an HP-TP or Aux-TP that have a high probability of eliciting T cell killing; and (iii) qualifying the sequence specificity based on the fold difference between the specific target and non-targets. |
地址 |
Southborough MA US |